Day: May 29, 2026

Black Book 2026 Payer Digital Technology Survey Establishes Rigorous 18-KPI Standard for Health Plan IT Client Satisfaction Rankings

Proprietary qualitative model evaluates payer technology, managed services, BPaaS, analytics, AI, cybersecurity, interoperability, clinical operations, administrative operations, and transformation partners...

Black Book 2026 Payer Digital Technology Survey Establishes Rigorous 18-KPI Standard for Health Plan IT Client Satisfaction Rankings

Proprietary qualitative model evaluates payer technology, managed services, BPaaS, analytics, AI, cybersecurity, interoperability, clinical operations, administrative operations, and transformation partners...

Sparrow Pharmaceuticals to Present Phase 2a Results for Clofutriben in Type 2 Diabetes at the 2026 American Diabetes Association (ADA) Scientific Session

BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the presentation of results...

New TECVAYLI®▼ (teclistamab) data demonstrate superior progression-free and overall survival versus standard of care as early as first relapse in multiple myeloma

MajesTEC-9 is the second positive Phase 3 study to reinforce the strength of Johnson & Johnson’s TECVAYLI® as early as...

Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits

Independent Cleveland Clinic Cardiac Review Supports Potential Best-in-Class Safety Profile as MIRACLE Phase 2b/3 Trial Advances HOUSTON, May 29, 2026...

SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting

Data will highlight deeper mechanistic insights and long-term dosing potential of SAB-142, a fully human multi-specific ATG for newly diagnosed...

error: Content is protected !!